KLSE (MYR): PHARMA (7081)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.345
Today's Change
+0.005 (1.47%)
Day's Change
0.34 - 0.35
Trading Volume
367,600
*** All look well.
*** Timely announcement: E&Y.
*** Improving biz trends.
*** Should be hot upon PN17 exit!
2024-09-25 10:46
I think market are just waiting for uplift of PN17. Look at Dpharma, already up so much. Soon will be us.
2024-09-26 16:43
price very stable at this pn17 lever.. think the opportunity once it cleared?
2024-09-27 09:07
bursa so lazy, its been mora than 6 month, not reply ..PMx should bur$4 activities which always favour the speculators!! so lazy la..
2024-10-11 14:28
this company falls under strategic and security for the nation, asclong as no corrupt or mismanagmnt.. gahmen will always give support. Previous disaster due to previous govt request to stockile vaccine ..in the end, they dont buy. Ltat n bousted..may be replaced by khazanah or pnb, kwsp.
1 month ago
this QR sure outstanding from govt supply and indonesia business.. Pharma even sub-con Duopharma
1 month ago
why you should buy at current price.. starting this year.. this company can produce and supply INSULIN!!.. next year current Biocon-Duopharma contract expired, and gov will have option to split at least to this company.
1 month ago
Extremely good QR result~ next will be announcement plan to exit pn17.. more upsides coming
1 month ago
company value $500m, one QR already $100m !! ... some more out from pn7 soon. .. end of this week 50 cents. End of this year 60-70 cents!! .. obat list from 600 to 800 items. And vaccine+ Insuline. RM 1 company.
1 month ago
any one can feedback or commend about the regulation plan ? is it a good thing or bad thing for shareholder ?
1 month ago
now everybody will scramble to get a piece of this company.. regulation plan approved, profit improving, insulin will generate lots of profits, ..TP 1.0 year end !
1 month ago
For pharmaceutical players, innovations like Pharmaniaga Bhd’s (KL:PHARMA) locally produced recombinant insulin, which received National Pharmaceutical Regulatory Agency (NPRA) approval in November, is set to launch in the first quarter of 2025, which reflects the sector’s evolution towards meeting chronic disease demands.
https://theedgemalaysia.com/node/737010
1 month ago
post pandemic ramai sakit teruk, gula takda cukai betapa lama, kini ramai ada kencing manis, big demand for ubat lagipun, aging society in malaysia terlalu ramai orang tua, sakit, ubat up up up
4 weeks ago
msia jugak negara teramai si gemuk di asia... good biz for phrma ramai ada penyakit kronik ya... ubat demand up like crazy diba
4 weeks ago
Profitable
<%-- for fixing scrollbar--%>
Save Print Back
7081 PHARMA PHARMANIAGA BHD
Quarterly rpt on consolidated results for the financial period ended 30/09/2024
Quarter: 3rd Quarter
Financial Year End: 31/12/2024
Report Status: Unaudited
Submitted By:
Current Year Quarter Preceding Year Corresponding Quarter Current Year to Date Preceding Year Corresponding Period
30/09/2024 30/09/2023 30/09/2024 30/09/2023
RM '000 RM '000 RM '000 RM '000
1 Revenue 1,029,822 885,486 2,833,037 2,614,674
2 Profit/Loss Before Tax 138,485 (56,259) 180,863 (40,724)
3 Profit/(loss) attributable to ordinary equity holders of the parent 101,032 (49,339) 129,475 (44,731)
4 Net Profit/Loss For The Period 101,319 (49,047) 131,344 (43,957)
5 Basic Earnings/Loss Per Shares (sen) 7.01 (3.67) 8.98 (3.33)
6 Dividend Per Share (sen) 0.00 0.00 0.00 0.00
As At End of Current Quarter As At Preceding Financial Year End
7 Net Assets Per Share (RM) (0.1214) (0.2075)
Remarks:
You are advised to read the entire contents of the announcement or attachment.
To read the entire contents of the announcement or attachment, please access
the Bursa website at http://www.bursamalaysia.com
26/11/2024 07:00 AM
Ref Code: 202411263100074
3 weeks ago
next month this counter sure fly!..FM can start fresh to reposition their funding start early next year, very soon out from PN17 status. Rock bottom price ..on SALE !
1 week ago
aging society... more n more pesakit... minta ubat dr hospital, dll... boleh boom balik ... dulu mistake over order vaksin kovid haha ...
1 week ago
The pharmaceutical business in Malaysia is expected to experience significant growth due to several key factors:
1. Aging Population
Malaysia, like many other countries, has an aging population. The proportion of elderly individuals is rising, which increases the demand for healthcare services and medications to manage chronic conditions associated with aging, such as cardiovascular diseases, diabetes, and cancer.
2. Growing Healthcare Needs
As the country develops, both the quality and demand for healthcare services are increasing. With an expanding middle class and better access to healthcare, people are more likely to seek medical treatments, which in turn drives demand for pharmaceuticals.
3. Government Support and Policy Initiatives
The Malaysian government has demonstrated a strong commitment to improving healthcare, including affordable access to medicines. The 12th Malaysia Plan (2021-2025) emphasizes healthcare improvement, making the pharmaceutical sector more attractive to investors. Policies to foster healthcare innovation, such as tax incentives and grants, can further support pharmaceutical companies.
4. Strategic Location for Regional Expansion
Malaysia's location in Southeast Asia makes it a key player for pharmaceutical companies looking to expand into neighboring ASEAN markets. The country's robust infrastructure, favorable trade agreements, and ease of logistics make it a strategic hub for pharmaceutical manufacturing and distribution.
5. Growing Medical Tourism
Malaysia is becoming a popular destination for medical tourism, especially for patients from neighboring countries seeking affordable, high-quality medical treatments. This surge in medical tourism drives demand for pharmaceuticals in hospitals and clinics catering to international patients.
6. Domestic Pharmaceutical Manufacturing Industry
Malaysia has a well-established local pharmaceutical manufacturing sector, which produces generic drugs, over-the-counter (OTC) medications, and even some specialized treatments. The government encourages local pharmaceutical production through incentives and initiatives that reduce reliance on imports.
7. Increased Focus on Research and Development (R&D)
Malaysia is focusing on research and development in the pharmaceutical and biotechnology sectors. The increasing collaboration between public and private sectors, academic institutions, and international pharmaceutical companies will likely spur innovation in drug development and production.
8. Rising Health Awareness
With an increasing focus on health and wellness, Malaysians are becoming more health-conscious. This includes a growing demand for vitamins, supplements, and alternative treatments, which boosts the pharmaceutical sector in terms of both traditional medicines and newer health-focused products.
9. Favorable Regulatory Environment
Malaysia has relatively efficient and streamlined regulatory procedures for pharmaceutical products. The National Pharmaceutical Regulatory Agency (NPRA) ensures that medicines are safe and effective, creating a stable and reliable environment for pharmaceutical companies.
10. Global Pharmaceutical Market Trends
As the global pharmaceutical market grows, Malaysia stands to benefit from international partnerships, joint ventures, and foreign direct investment. Its competitive manufacturing base and skilled workforce provide a solid foundation for pharmaceutical companies aiming to meet international demand.
In conclusion, the pharmaceutical business in Malaysia is poised to boom due to demographic shifts, government initiatives, strategic positioning, a well-established industry, and increased healthcare demand. These factors make it an attractive market for both local and international pharmaceutical companies.
5 days ago
Malaysia has one of the highest rates of obesity in Southeast Asia and is often ranked among the countries with the highest obesity rates globally. According to recent reports:
Obesity in Malaysia
Rising Obesity Rates:
Malaysia is experiencing a significant obesity crisis. The World Population Review and other health reports have shown that Malaysia has one of the highest obesity rates in Asia. About 50-60% of the adult population in Malaysia is either overweight or obese.
Diet and Lifestyle:
The high obesity rates can be attributed to several factors, including poor diet, with an increased consumption of fast food, sugary drinks, and processed foods. Additionally, physical inactivity, urbanization, and sedentary lifestyles have contributed to the problem.
Health Risks:
The increasing prevalence of obesity in Malaysia is concerning due to the associated health risks, such as cardiovascular diseases, diabetes, and other chronic conditions. This has significant implications for the country's healthcare system, with rising medical costs and a growing burden on healthcare services.
Government and Public Health Efforts
In response, the Malaysian government has been taking steps to tackle obesity and promote healthier lifestyles. Initiatives include public health campaigns, regulations on food labeling, and promoting physical activity.
So, while Malaysia is not the "fattest country in the world", it does have a high rate of obesity, which is a growing concern for public health.
5 days ago
Yes, obesity in Malaysia is contributing to a growing public health crisis, and many people are facing serious health problems that require medication or treatment. The combination of high obesity rates and the associated health complications has placed a significant burden on the healthcare system. Here's a breakdown of the issue:
Health Problems Linked to Obesity in Malaysia
Diabetes:
Malaysia has one of the highest rates of diabetes in the world, and obesity is a major risk factor. Many Malaysians, especially those who are overweight or obese, develop Type 2 diabetes. This condition requires lifelong management, often with medication, insulin, and regular monitoring.
Cardiovascular Diseases:
Obesity significantly increases the risk of heart disease, high blood pressure, and stroke. Many Malaysians suffering from obesity need medications to manage high cholesterol, hypertension, or heart disease.
Joint Problems:
Excess weight can lead to chronic joint pain, particularly in the knees and hips. Osteoarthritis is a common condition among obese individuals, which may require medication for pain management or even surgery.
Sleep Apnea:
Obesity is a leading cause of sleep apnea, a condition where breathing repeatedly stops and starts during sleep. This condition often requires continuous positive airway pressure (CPAP) treatment or other forms of medical intervention.
Cancer:
Obesity increases the risk of several types of cancer, such as breast cancer, colon cancer, and endometrial cancer. The link between obesity and cancer is well-documented, and many people with obesity require specialized treatments, including chemotherapy and other medications.
Mental Health Issues:
Obesity can also contribute to depression, anxiety, and low self-esteem. While mental health issues are not always directly treated with medication for everyone, some obese individuals may require antidepressants or other mental health treatments.
Challenges in Malaysia's Healthcare System
Increased Healthcare Costs: As more people develop obesity-related diseases, the demand for healthcare services and medication increases. This can lead to higher healthcare costs, both for individuals and the government.
Prevalence of Chronic Diseases: The rise in chronic diseases like diabetes and hypertension means that a large portion of the population requires long-term medications and healthcare support.
Medication Use in Malaysia
Many Malaysians suffering from obesity-related health problems rely on medications to manage their conditions. For instance, medications to control blood sugar, blood pressure, cholesterol, and pain from arthritis are commonly prescribed. Some individuals may also be prescribed weight loss medications to assist in managing obesity.
Prevention and Solutions
Efforts are being made to address this issue, but there is still a need for more effective prevention and treatment strategies. These include:
Public health campaigns to encourage healthier eating habits, physical activity, and weight management.
Government programs aimed at reducing the prevalence of obesity through better education on nutrition, exercise, and lifestyle choices.
Healthcare reforms to ensure access to treatments and medications for those who need them.
In summary, due to the high obesity rates, a significant portion of Malaysia's population faces serious health issues, many of which require medication. The government, healthcare providers, and the public need to focus on both prevention (such as promoting healthier lifestyles) and effective treatment options to address the obesity epidemic and its associated health problems.
5 days ago
Ya, obesiti di Malaysia sedang menyumbang kepada krisis kesihatan awam yang semakin meningkat, dan ramai orang menghadapi masalah kesihatan serius yang memerlukan ubat atau rawatan. Gabungan kadar obesiti yang tinggi dan komplikasi kesihatan yang berkaitan telah meletakkan beban besar pada sistem penjagaan kesihatan. Berikut adalah gambaran keseluruhan mengenai isu ini:
Masalah Kesihatan Berkaitan Obesiti di Malaysia
Diabetes:
Malaysia mempunyai salah satu kadar diabetes yang tertinggi di dunia, dan obesiti adalah faktor risiko utama. Ramai rakyat Malaysia, terutamanya yang berlebihan berat badan atau obes, menghidap diabetes jenis 2. Keadaan ini memerlukan pengurusan sepanjang hayat, selalunya dengan ubat-ubatan, insulin, dan pemantauan berkala.
Penyakit Kardiovaskular:
Obesiti secara signifikan meningkatkan risiko penyakit jantung, tekanan darah tinggi, dan strok. Ramai rakyat Malaysia yang mengalami obesiti memerlukan ubat untuk menguruskan kolesterol tinggi, hipertensi, atau penyakit jantung.
Masalah Sendi:
Berat badan yang berlebihan boleh menyebabkan kesakitan sendi kronik, terutamanya pada lutut dan pinggul. Osteoartritis adalah keadaan biasa di kalangan individu obes, yang mungkin memerlukan ubat untuk pengurusan kesakitan atau bahkan pembedahan.
Sleep Apnea:
Obesiti adalah penyebab utama sleep apnea, keadaan di mana pernafasan berhenti dan bermula semula secara berulang semasa tidur. Keadaan ini selalunya memerlukan rawatan CPAP (Continuous Positive Airway Pressure) atau bentuk rawatan perubatan lain.
Kanser:
Obesiti meningkatkan risiko beberapa jenis kanser, seperti kanser payudara, kanser kolon, dan kanser endometrial. Hubungan antara obesiti dan kanser telah dibuktikan, dan ramai orang dengan obesiti memerlukan rawatan khas, termasuk kemoterapi dan ubat-ubatan lain.
Masalah Kesihatan Mental:
Obesiti juga boleh menyumbang kepada kemurungan, kerisauan, dan rendah diri. Walaupun masalah kesihatan mental tidak selalu dirawat dengan ubat-ubatan bagi semua orang, sesetengah individu obes mungkin memerlukan antidepresan atau rawatan kesihatan mental yang lain.
Cabaran dalam Sistem Penjagaan Kesihatan Malaysia
Kos Penjagaan Kesihatan yang Meningkat: Dengan semakin ramai orang yang menghidap penyakit berkaitan obesiti, permintaan untuk perkhidmatan penjagaan kesihatan dan ubat-ubatan semakin meningkat. Ini boleh membawa kepada kos penjagaan kesihatan yang lebih tinggi, baik bagi individu mahupun kerajaan.
Prevalens Penyakit Kronik: Peningkatan penyakit kronik seperti diabetes dan hipertensi bermakna sebahagian besar populasi memerlukan ubat-ubatan jangka panjang dan sokongan penjagaan kesihatan.
Penggunaan Ubat di Malaysia
Ramai rakyat Malaysia yang mengalami masalah kesihatan berkaitan obesiti bergantung pada ubat-ubatan untuk menguruskan keadaan mereka. Contohnya, ubat untuk mengawal paras gula darah, tekanan darah, kolesterol, dan kesakitan daripada artritis adalah ubat yang biasa diberikan. Sesetengah individu juga mungkin diberi ubat penurunan berat badan untuk membantu menguruskan obesiti.
Pencegahan dan Penyelesaian
Langkah-langkah sedang diambil untuk menangani isu ini, tetapi masih terdapat keperluan untuk strategi pencegahan dan rawatan yang lebih berkesan. Ini termasuk:
Kempen kesihatan awam untuk menggalakkan tabiat pemakanan yang lebih sihat, aktiviti fizikal, dan pengurusan berat badan.
Program kerajaan yang bertujuan untuk mengurangkan prevalens obesiti melalui pendidikan yang lebih baik mengenai pemakanan, senaman, dan pilihan gaya hidup.
Reformasi penjagaan kesihatan untuk memastikan akses kepada rawatan dan ubat-ubatan bagi mereka yang memerlukannya.
Kesimpulannya, disebabkan kadar obesiti yang tinggi, sebahagian besar populasi Malaysia menghadapi masalah kesihatan serius, yang mana banyak memerlukan ubat-ubatan. Kerajaan, penyedia penjagaan kesihatan, dan masyarakat perlu memberi tumpuan kepada kedua-dua pencegahan (seperti mempromosikan gaya hidup yang lebih sihat) dan pilihan rawatan yang berkesan untuk menangani wabak obesiti dan masalah kesihatan yang berkaitan.
5 days ago
Kayalah hehe
Memang benar bahawa industri farmaseutikal di Malaysia semakin berkembang, dan salah satu faktor utama adalah peningkatan masalah kesihatan yang semakin serius di kalangan rakyat. Jumlah rakyat Malaysia yang menghidap pelbagai penyakit kronik, seperti obesiti, diabetes, penyakit kardiovaskular, dan masalah kesihatan lain, semakin meningkat, yang menyumbang kepada permintaan yang tinggi terhadap ubat-ubatan dan rawatan kesihatan.
Faktor-Faktor Yang Menyumbang Kepada Keuntungan Industri Farmaseutikal di Malaysia:
Peningkatan Penyakit Kronik:
Seperti yang telah dibincangkan sebelum ini, kadar obesiti dan penyakit kronik seperti diabetes, hipertensi, dan penyakit jantung semakin meningkat di Malaysia. Keadaan ini meningkatkan keperluan untuk ubat-ubatan yang dapat menguruskan keadaan tersebut.
Penyakit kronik juga meningkatkan keperluan untuk rawatan jangka panjang, yang mengakibatkan penggunaan ubat yang berterusan, baik di peringkat individu mahupun di hospital dan klinik.
Permintaan untuk Ubat dan Rawatan:
Dengan peningkatan jumlah pesakit yang memerlukan rawatan untuk penyakit kronik, permintaan terhadap ubat-ubatan, alat perubatan, dan rawatan perubatan semakin meningkat. Ubat-ubatan untuk mengawal penyakit seperti diabetes, tekanan darah tinggi, dan kolesterol tinggi menjadi sangat diperlukan.
Selain itu, rawatan untuk penyakit berkaitan obesiti, seperti sakit sendi, masalah tidur, dan risiko kanser, turut memacu permintaan terhadap produk farmaseutikal.
Peluang untuk Pembuatan Ubat Generik:
Malaysia mempunyai industri farmaseutikal tempatan yang berdaya saing, dengan banyak syarikat menghasilkan ubat generik yang lebih murah. Ini memberikan peluang kepada syarikat farmaseutikal untuk memenuhi permintaan yang tinggi di pasaran tempatan, serta menjadikan Malaysia sebagai pengeluar dan pembekal utama ubat generik di pasaran global.
Kualiti ubat generik yang dihasilkan di Malaysia juga semakin diiktiraf di peringkat antarabangsa, yang membuka peluang eksport.
Sokongan Kerajaan:
Kerajaan Malaysia telah memberikan perhatian terhadap sektor farmaseutikal dengan menyediakan pelbagai insentif untuk memperkukuhkan industri ini, termasuk dalam bidang penyelidikan dan pembangunan (R&D). Inisiatif kerajaan seperti Program Insentif Penyelidikan Farmaseutikal dan Pengurangan Cukai dapat merangsang pelaburan dalam inovasi farmaseutikal, menggalakkan lebih banyak penyelidikan untuk pembangunan ubat baru dan rawatan inovatif.
Peranan Malaysia dalam Perdagangan ASEAN:
Malaysia merupakan negara yang strategik di rantau ASEAN, yang memberi peluang kepada syarikat farmaseutikal untuk mengembangkan perniagaan mereka ke pasaran serantau. Infrastruktur yang baik dan akses kepada negara-negara jiran menjadikan Malaysia sebagai hub pengeluaran farmaseutikal di Asia Tenggara.
Peningkatan Kesedaran Kesihatan:
Dengan kesedaran masyarakat yang semakin tinggi terhadap kesihatan dan pemakanan, permintaan terhadap ubat tambahan, vitamin, dan suplimen turut meningkat. Masyarakat kini lebih peka terhadap gaya hidup sihat dan pencegahan penyakit, yang turut menyumbang kepada pertumbuhan industri farmaseutikal.
Kesimpulan:
Industri farmaseutikal di Malaysia berpotensi terus berkembang pesat kerana meningkatnya jumlah pesakit dengan masalah kesihatan yang serius dan kronik. Ini memberi peluang yang besar kepada syarikat farmaseutikal untuk memenuhi permintaan yang tinggi untuk ubat-ubatan, rawatan, dan penyelesaian kesihatan. Selain itu, dengan sokongan kerajaan, peluang eksport, dan peranan Malaysia sebagai hub pembuatan farmaseutikal di Asia Tenggara, sektor ini akan terus menjadi salah satu sektor yang memberi keuntungan yang lumayan di Malaysia.
5 days ago
Huatlah hehe
It is indeed true that the pharmaceutical industry in Malaysia is growing, and one of the main factors is the increasing prevalence of serious health problems among the population. The number of Malaysians suffering from chronic diseases such as obesity, diabetes, cardiovascular diseases, and other health issues is on the rise, contributing to the high demand for medicines and healthcare treatments.
Factors Contributing to the Growth of the Pharmaceutical Industry in Malaysia:
Increase in Chronic Diseases:
As discussed earlier, obesity rates and chronic diseases like diabetes, hypertension, and heart disease are rising in Malaysia. This situation increases the need for medications to manage these conditions.
Chronic diseases also require long-term treatments, which leads to continued medication usage, both at the individual level and within hospitals and clinics.
Demand for Medicines and Treatments:
With the rising number of patients needing treatment for chronic diseases, the demand for medications, medical devices, and medical treatments is increasing. Medicines to control conditions such as diabetes, high blood pressure, and high cholesterol are in high demand.
In addition, treatments for obesity-related diseases, such as joint pain, sleep issues, and cancer risk, further drive the demand for pharmaceutical products.
Opportunities for Generic Drug Manufacturing:
Malaysia has a competitive local pharmaceutical industry, with many companies producing generic drugs at more affordable prices. This creates opportunities for pharmaceutical companies to meet the high demand in the local market, as well as establish Malaysia as a key manufacturer and supplier of generic drugs in the global market.
The quality of generic drugs produced in Malaysia is increasingly recognized internationally, opening up export opportunities.
Government Support:
The Malaysian government has shown strong commitment to the pharmaceutical sector by providing various incentives to strengthen the industry, particularly in the areas of research and development (R&D). Government initiatives like the Pharmaceutical Research Incentive Program and Tax Reductions stimulate investment in pharmaceutical innovation, encouraging more research into the development of new medicines and treatments.
Malaysia’s Role in ASEAN Trade:
Malaysia is strategically located in the ASEAN region, providing opportunities for pharmaceutical companies to expand their businesses into neighboring markets. The country's strong infrastructure and access to neighboring countries make Malaysia a key hub for pharmaceutical production in Southeast Asia.
Increased Health Awareness:
With rising public awareness of health and nutrition, the demand for supplements, vitamins, and health-related products has also grown. People are becoming more conscious of healthy lifestyles and disease prevention, contributing to the growth of the pharmaceutical sector.
Conclusion:
The pharmaceutical industry in Malaysia is poised to continue its growth due to the increasing number of people suffering from serious and chronic health problems. This presents a great opportunity for pharmaceutical companies to meet the rising demand for medicines, treatments, and healthcare solutions. Additionally, with government support, export opportunities, and Malaysia's role as a pharmaceutical manufacturing hub in Southeast Asia, this sector is set to remain one of the most lucrative industries in Malaysia.
5 days ago
Masalah obesiti di Malaysia memang menjadi salah satu krisis kesihatan yang semakin serius. Berikut adalah beberapa fakta dan isu utama berkaitan krisis obesiti di Malaysia:
Statistik Obesiti di Malaysia
1. Tertinggi di Asia Tenggara: Malaysia mencatat kadar obesiti tertinggi di Asia Tenggara. Menurut laporan Kementerian Kesihatan, lebih daripada 50% orang dewasa Malaysia mengalami berat badan berlebihan atau obesiti.
2. Obesiti kanak-kanak: Kira-kira 1 daripada 5 kanak-kanak Malaysia mengalami obesiti, menjadikan ia cabaran besar untuk generasi akan datang.
Punca Utama Obesiti
1. Gaya Hidup Tidak Aktif: Ramai rakyat Malaysia kurang bersenam kerana kerja pejabat, penggunaan kenderaan, dan kurangnya budaya bersenam.
2. Diet Tidak Sihat:
• Pengambilan makanan tinggi kalori, gula, dan lemak (seperti nasi lemak, teh tarik, makanan segera).
• Penggunaan gula dalam makanan dan minuman, termasuk minuman manis yang sangat popular di Malaysia.
3. Tekanan Hidup & Pemakanan Emosi: Tekanan kerja dan kehidupan sering mendorong pemakanan berlebihan sebagai cara menangani emosi.
4. Kurangnya Pendidikan Kesihatan: Ramai yang kurang kesedaran tentang kepentingan pemakanan seimbang dan aktiviti fizikal.
Kesan Obesiti
1. Masalah Kesihatan Kronik:
• Diabetes jenis 2: Malaysia mencatat salah satu kadar tertinggi di dunia.
• Hipertensi dan penyakit jantung.
• Masalah ortopedik seperti sakit lutut dan sendi.
2. Kos Ekonomi: Krisis obesiti memberi tekanan besar kepada sistem penjagaan kesihatan dan meningkatkan kos rawatan penyakit kronik.
Langkah-Langkah yang Perlu Diambil
1. Kempen Kesedaran:
• Program seperti Kempen Kurangkan Gula perlu lebih agresif.
• Pendidikan kesihatan dalam sekolah dan komuniti.
2. Cukai Minuman Bergula (Sugar Tax):
• Kerajaan Malaysia telah memperkenalkan cukai ini, tetapi keberkesanannya perlu dipertingkatkan.
3. Memupuk Gaya Hidup Aktif:
• Membina lebih banyak taman dan kemudahan awam untuk bersenam.
• Menyediakan insentif untuk aktiviti sukan di tempat kerja.
4. Dasar Pemakanan:
• Mengawal iklan makanan tidak sihat, terutamanya kepada kanak-kanak.
• Meningkatkan ketersediaan makanan sihat pada harga mampu milik.
Cadangan Peribadi
Untuk individu, langkah kecil boleh membantu:
• Kurangkan makanan tinggi gula dan lemak.
• Tingkatkan aktiviti fizikal (30 minit senaman ringan sehari).
• Ambil makanan lebih banyak serat seperti buah-buahan dan sayur-sayuran.
• Dapatkan pemeriksaan kesihatan berkala.
5 days ago
ramai si gemuk , obesiti masalah yg besar disini... ubat laris macam jualan kek ya
4 days ago
XinXin Chan
Auditor resign.....gg.com
2024-09-23 22:50